Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

In phase I studies, lobaplatin showed activity in ovarian cancer patients pretreated with platinum. A phase II trial with lobaplatin was performed in patients with refractory or relapsed ovarian cancer to define activity and pharmacokinetics. Twenty-two patients were treated with lobaplatin administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Gietema, J. A., Veldhuis, G. J., Guchelaar, H. J., Willemse, P. H., Uges, D. R., Cats, A., Boonstra, H., van der Graaf, W. T., Sleijfer, D. T., de Vries, E. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033845/
https://www.ncbi.nlm.nih.gov/pubmed/7779728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033845/
https://www.ncbi.nlm.nih.gov/pubmed/7779728

Ejemplares similares